Navigation Links
Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
Date:4/8/2008

he improvements were achieved without any limiting next day cognitive effects. In both the Phase 1 program and the Phase 2a trial, APD125 was well tolerated at all doses investigated.

About APD125

Discovered by Arena, APD125 is a novel and oral selective inverse agonist of the 5-HT2A serotonin receptor. The vast majority of approved drugs for insomnia activate the GABA-A receptor complex in the brain, causing a general suppressive effect on the central nervous system, or CNS. These GABAergic drugs are generally associated with CNS side effects, including a sensation of dullness and lethargy upon awakening, often referred to as the "hangover effect." Other potential problems associated with the GABAergic drugs include the risk of developing tolerance and drug dependency in at-risk populations. In addition, GABAergic drugs are scheduled controlled substances by the Drug Enforcement Administration due to their potential for abuse.

By selectively targeting the 5-HT2A receptor, APD125 acts through a different mechanism than currently marketed insomnia drugs and blocks one of several CNS activating pathways. Because of the different mechanism of action, APD125 may not have the side effects or abuse potential generally associated with currently approved GABAergic drugs. Through its novel mechanism, APD125 has the potential to reduce insomnia symptoms by improving sleep maintenance.

About Insomnia

Insomnia is characterized by inadequate or poor sleep due to nonrefreshing sleep, frequent wakening with difficulty falling back to sleep, difficulty falling asleep or waking too early. Most insomnia complaints relate to sleep maintenance issues, such as waking frequently or awakening too early, as opposed to problems with sleep latency (i.e. falling asleep). About 30% of US adults report some level of insomnia in the course of a year, and about 10% of US adults indicate that their condition is chronic. In these cases, the lack of restful sleep i
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Arena Pharmaceuticals to Present at Four Upcoming Investor Conferences
2. Arena Pharmaceuticals Announces Positive Phase 2 Clinical Trial Results of APD125 for the Treatment of Insomnia
3. Arena Pharmaceuticals Announces APD668 Initial Clinical Study Results Suggest Glucose-Dependent Insulinotropic Receptors May Improve Glucose Control in Patients With Type 2 Diabetes
4. Arena Pharmaceuticals Announces Positive Phase 1a Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis and Initiates Phase 1b Clinical Trial
5. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
6. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
7. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
8. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
9. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
10. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
11. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...ortlinker.comannouncesthatanewmarketresearchreport...agnosticImagingMarketto2015 ,, http://www.re...ic-Imaging-Market-to-2015.html#utm_source=prnewswi... ,, Description ,, TheFutureoftheDiagnos...lMarketsDirect,s"TheFutureoftheDiagnosticImagingMa...
(Date:11/23/2009)...ortlinker.comannouncesthatanewmarketresearchreport...tems&Equipment-AGlobalMarketPerspective ,,...ion-Systems--Equipment---A-Global-Market-Perspecti...p;utm_campaign=prnewswire ,, Steamsteriliza...edure.Steamsterilizationmarketisstableduetoregulat...
(Date:11/23/2009)...ov.23/PRNewswire-USNewswire/--JubilantOrganosys,th...esearchInstitutetodayannouncedajointventurethatwil...lingtechnologiesintheareasofOncology,MetabolicDise...tragedandleveragedpartnershipthatwillacceleratethe...de.AMemorandumofUnderstandingwassignedtodayinWashi...
Breaking Medicine Technology:Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 2Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 3Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 4Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 5Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 6Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 7Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 8Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 9Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 10Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 11Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 2Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 3Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 4Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 5Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 6Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 7Jubilant Organosys, UAB and Southern Research Enter Into Drug Discovery Joint Venture 2Jubilant Organosys, UAB and Southern Research Enter Into Drug Discovery Joint Venture 3Jubilant Organosys, UAB and Southern Research Enter Into Drug Discovery Joint Venture 4Go to the doctor 3F Only if Im really sick 52254 1Go to the doctor 3F Only if Im really sick 52254 2When children have breathing problems 9297 1When children have breathing problems 9297 2When children have breathing problems 9297 3Ethiopian government celebrates rinderpest eradication 9294 1Ethiopian government celebrates rinderpest eradication 9294 2Ethiopian government celebrates rinderpest eradication 9294 3
(Date:11/23/2009)...essionals enjoy a pay raise for a job well done. B...lth care performance may actually backfire. , ...nce ratings for 25 medical groups across Californi... statewide pay-for-performance program in 2004 bu...vity. , Reporting in the December edition of ...
(Date:11/23/2009)...hemo deal with insomnia, study shows , ,...sleep disorders affect more than three-quarters of...early three times higher than that of the general ... more common in younger patients and in those with...ster Medical Center researchers, who assessed slee...
(Date:11/23/2009)... approval process in United States, researcher say...- Problems with the popular arthritis drug Vioxx, ...and death, were known for years before the drug,s ...w report says. , Contrary to claims by the man... were evident in 2000, a year after the drug was p...
(Date:11/23/2009)...anksin Washington D.C. , NewYork , N.Y. ,...ntendedtoSpurEconomicGrowthandRevitalization ,...,thenation,sleadingproviderofdialysisservices,toda...dtocreatejobsandspurrevitalizationinminoritycommun...nityandminority-ownedbanks.DaVitahasdonated$5milli...
(Date:11/23/2009)...- ,, WHAT: ,, TheBerylInstitute, theresea...n,sleadinghealthcareexclusivecallcenter,issponsori...erygenerationwithapositivecustomerserviceexperienc...WebinarwillsupplementHowe,sJune2009whitepaper,"Cus...cusseshowconsumerswillultimatelytransformhealthcar...
Breaking Medicine News(10 mins):Health News:Medical 'pay for performance' programs help improve care -- but not always, study finds 2Health News:Medical 'pay for performance' programs help improve care -- but not always, study finds 3Health News: Vioxx Problems Known Years Before Recall 2Health News: Vioxx Problems Known Years Before Recall 3Health News: Vioxx Problems Known Years Before Recall 4Health News:DaVita Launches Minority Bank Initiative with $5 Million Investment in Underserved Communities Across the Country 2Health News:DaVita Launches Minority Bank Initiative with $5 Million Investment in Underserved Communities Across the Country 3Health News:Tips to Improve Healthcare Customer Service Across All Generations 2
...n recognized as one of the most neurotoxic plants ... berries of C. myrtifolia are known to be neurotox...at is present in high concentrations in the berrie...recent paper in the November issue of Toxicon, pre...
...ve discovered that a deceptively simple sugar is i... cycle.// The discovery reveals that, when di...r other diseases by failing to properly control th...ify proteins, turning the proteins off or on, help...
...and his colleagues from the Institute of Child Hea...ren’s who were born premature.// The study will fo...their life time. The study will help to identify a...on Medical Research, UK. The research team woul...
... from poor families who get fed in schools by the ...help make up for their iron and vitamin deficienci... to iron pills, which have not found wide acceptan... anaemia. The nutrition candy however should be se...
... been receptive enough to hold on to technological... delivery. One such has been the adoption of compu...are in a cost effective way//. It has now been...ers that can have valuable implications on the tre...
...emic encephalopathy due to acute perinatal asphyxi... deficits in childhood//. Infants with moderat...se who survive have a 30% risk of disabilities. 60... care. Hypothermia has previously been found to be...
Other Medicine News:Health News:Poisoning by fruits similar to blackberries 2Health News:Sugar Helps Control Cell Division 2Health News:New Research To Study Brain Changes In Premature Births 2Health News:Vitamin filled nutrition candy for School children 2Health News:Computers Can Teach Patients About Screening for Cancer 2Health News:Whole-body hypothermia reduces risk of death in Encephalopathy in infants 2
Pectoralis Implants
...izes. Long-term implantable, soft medical grade si.... Each preformed block can be easily trimmed or mo...n patient., Carving Blocks are solid silicone and ...f surgical options for augmentation of tissue or b...
...ing extension of the IQmark Diagnostic Workstation...based PC to deliver unmatched speed, accuracy and ...download and seamlessly integrate test results int...e. The point-and-click functionality eliminates th...
...ransformation in less than an hour with the Obagi ...her superficial procedures, the Obagi Blue Peel pu...ur patients' particular skin needs, you determine ... peels and number of coats applied. A blue mixing ...
Medicine Products: